FDA updates labeling for OBREDON
Labeling changes approved for SOVEREIGN PHARMS. Active ingredient: GUAIFENESIN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025
Labeling changes approved for SOVEREIGN PHARMS. Active ingredient: GUAIFENESIN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025
There are no comments here yet...